Abstracts - faqs.org

Abstracts

Zoology and wildlife conservation

Search abstracts:
Abstracts » Zoology and wildlife conservation

Requirement for IRF-1 int he microenvironment supporting development of natural killer cells

Article Abstract:

Natural killer (NK) cells are crucial for both innate and adaptive immunity and their development requires interactions between their progenitors and the bone marrow. The molecular nature of such interactions is not well known. It is now demonstrated that the lack of interferon-regulatory factor-1 (IRF-1) has an affect on radiation resistant cells constituting the environment needed for NK-cell development.

Author: Ogasawara, Kouetsu, Waldmann, Thomas A., Taniguchi, Tadatsugu, Taki, Shinsuke, Hida, Shigeaki, Asimi, Nazli, Tagaya, Yutaka, Sato, Takeo, Yokochi, Fukuda, Taeko
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1998
Killer cells

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage

Article Abstract:

Embryonic fibroblasts lacking interferon regulatory factor (IRF)-1 and the tumour suppressor p53 are unable to undergo cell-cycle arrest in response to DNA damage, although the expression of both is independent of one another. The two transcription factors converge functionally in encoding p21, a cell-cycle inhibitor, and thus control the cell cycle through the stimulation of common target genes.

Author: Mak, Tak W., Oren, Moshe, Matsuyama, Toshifumi, Taniguchi, Tadatsugu, Tanaka, Nobuyuki, Aizawa, Shinichi, Ishihara, Masahiko, Lamphier, Marc S., Nozawa, Hiroaki, Tokino, Takashi
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1996
Analysis, Radiation, Radiation (Physics), DNA damage, Cell cycle

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes

Article Abstract:

Interferon regulatory factor (IRF)-1 appears to be a tumor suppressor whose inactivation may be linked with myelodysplastic syndrome and leukemia development. There may be two different DNA damage-induced apoptosis pathways for T lymphocytes. IRF-1 appears to function in mitogen-stimulated mature T lymphocytes while the previously accepted p53 pathway functions in thymocytes.

Author: Mak, Tak W., Matsuyama, Toshifumi, Taniguchi, Tadatsugu, Tanaka, Nobuyuki, Aizawa, Shinichi, Tamura, Tomohiko, Ishihara, Masahiko, Lamphier, Marc S., Oishi, Isao, Taki, Shinsuke
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1995
Physiological aspects, Cell death, T cells

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Observations, Research, Tumor suppressor genes
Similar abstracts:
  • Abstracts: Habitat use of fox squirrels in an urban environment. Texas Latino college student attitudes toward natural resources and the environment
  • Abstracts: Reaching for the moon. China blasts off on lunar exploration
  • Abstracts: Temporal aspects in the development of Belding's ground squirrels' litter-mate preferences. The ontogeny of littermate preferences in juvenile golden-mantled ground squirrels: effects of rearing and relatedness
  • Abstracts: Crick's resignation heralds new era for Salk. Salk Institute investigated after claims of inhumane research. Leadership wrangle forces Salk Institute restructuring
  • Abstracts: Microscopic coexistence of magnetism and superconductivity in ErNi2B2C. Structural evidence for a two-step process in the depinning of the superconducting flux-line lattice
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.